Home > Simulations Plus Salary

Simulations Plus Salary

  • 49
  • 30
  • 60
Simulations Plus average salary is $81,219, median salary is $76,751 with a salary range from $67,371 to $104,000.
Simulations Plus salaries are collected from government agencies and companies. Each salary is associated with a real job position. Simulations Plus salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 3 Simulations Plus Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Sap Business Analyst 104,000-104,000 Redmond, WA, 98052 2013 Simulations Plus Sap Business Analyst Salaries (2)
Simulations Plus Redmond, WA Salaries
Systems Analyst 76,502-77,000 Stafford, TX, 77477 2013 Simulations Plus Systems Analyst Salaries (2)
Simulations Plus Stafford, TX Salaries
Sap Business Analyst 67,371-67,371 Redmond, WA, 98052 2012 Simulations Plus Sap Business Analyst Salaries (2)
Simulations Plus Redmond, WA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Simulations Plus salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Simulations Plus Jobs
See more Simulations Plus Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Simulations Plus... Information
  • Simulations Plus, Inc
  • Industry: Biotech/Healthcare
  • City: Lancaster, CA
  • Simulations Plus, Inc. is the leading developer of Absorption, Distribution, Metabolism and Excretion (ADME) neural net and simulation software for the pharmaceutical and biotechnology industries today. The Company¡¯s software allows pharmaceutical scientists to predict certain key potential drug dynamics, such as absorption, in silico, thereby eliminating multi-million dollar clinical trial failures and speeding up the time to market of effective new medications.